Practical Geriatrics ›› 2026, Vol. 40 ›› Issue (2): 121-125.doi: 10.3969/j.issn.1003-9198.2026.02.004
Previous Articles Next Articles
LI Jiachun, YAN Li, LIU Jiye, SUN Weimin
Received:2025-12-15
Online:2026-02-20
Published:2026-02-27
Contact:
SUN Weimin, Email: swm_1773@163.com
CLC Number:
LI Jiachun, YAN Li, LIU Jiye, SUN Weimin. Research progress on drug targets for sleep disorders in the elderly[J]. Practical Geriatrics, 2026, 40(2): 121-125.
| [1] HÖGL B, ARNULF I, BERGMANN M, et al. Rapid eye movement sleep behaviour disorder: past, present, and future[J]. J Sleep Res, 2022, 31(4): e13612. [2] JAQUA E E, HANNA M, LABIB W, et al. Common sleep disorders affecting older adults[J]. Perm J, 2023, 27(1): 122-132. [3] IRANZO A, COCHEN DE COCK V, FANTINI M L, et al. Sleep and sleep disorders in people with Parkinson’s disease[J]. Lancet Neurol, 2024, 23(9): 925-937. [4] TATINENY P, SHAFI F, GOHAR A, et al. Sleep in the elderly[J]. Mo Med, 2020, 117(5): 490-495. [5] FEINSILVER S H. Normal and abnormal sleep in the elderly[J]. Clin Geriatr Med, 2021, 37(3): 377-386. [6] PAPPAS J A, MINER B. Sleep deficiency in the elderly[J]. Sleep Med Clin, 2024, 19(4): 593-606. [7] HUNT C A, MUN C J, OWENS M A, et al. Sleep, positive affect, and circulating interleukin-6 in women with temporomandibular joint disorder[J]. Psychosom Med, 2022, 84(3): 383-392. [8] OKS M, FEINSILVER S H. Sleep in the elderly: a common and growing problem[J]. Clin Geriatr Med, 2021, 37(3): ix-x. [9] GLEESON M, MCNICHOLAS W T. Bidirectional relationships of comorbidity with obstructive sleep apnoea[J]. Eur Respir Rev, 2022, 31(164):210-256. [10] HERTENSTEIN E, TRINCA E, WUNDERLIN M, et al. Cognitive behavioral therapy for insomnia in patients with mental disorders and comorbid insomnia: a systematic review and meta-analysis[J]. Sleep Med Rev, 2022, 62: 101597. [11] KIM J H, ELKHADEM A R, DUFFY J F. Circadian rhythm sleep-wake disorders in older adults[J]. Sleep Med Clin, 2022, 17(2): 241-252. [12] HUO S, CHENG L, LI S, et al. Effects of eszopiclone on sleep quality and cognitive function in elderly patients with Alzheimer’s disease and sleep disorder: a randomized controlled trial[J]. Brain Behav, 2022, 12(2): e2488. [13] POURMOTABBED A, BOOZARI B, BABAEI A, et al. Sleep and frailty risk: a systematic review and meta-analysis[J]. Sleep Breath, 2020, 24(3): 1187-1197. [14] ADIT I, SINGH S K, JAISWAL A K, et al. Is there a ubiquitous association between sleep disorder and frailty findings from LASI (2017-18)[J]. BMC Geriatr, 2023, 23(1):429. [15] HONDA H, ASHIZAWA R, KIRIYAMA K, et al. Chronic pain in the frail elderly mediates sleep disorders and influences falls[J]. Arch Gerontol Geriatr, 2022, 99: 104582. [16] MINER B, KRYGER M H. Sleep in the aging population[J]. Sleep Med Clin, 2020, 15(2): 311-318. [17] GETANEH F W, SUSSMAN R D, IGLESIA C B. Nocturia: evaluation and management[J]. Am Fam Physician, 2025, 111(6): 515-523B. [18] WILSON M A, SUMERA A, TAYLOR L W, et al. Phylogenetic divergence of GABA(B) receptor signaling in neocortical networks over adult life[J]. Nat Commun, 2025, 16(1): 4194. [19] CHEN Y R, SCHULZ P J. The effect of information communication technology interventions on reducing social isolation in the elderly: a systematic review[J]. J Med Internet Res, 2016, 18(1): e18. [20] CONDON A F, ASAD N, DORE T M, et al. Co-activation of GPCRs facilitate GIRK-dependent current[J]. J Physiol, 2022, 600(22): 4881-4895. [21] TOOR B, RAY B L, POZZOBON A, et al. Sleep, orexin and cognition[J]. Front Neurol Neurosci, 2021, 45:38-51. [22] DAUVILLIERS Y, PLAZZI G, MIGNOT E, et al. Oveporexton, an oral orexin receptor 2-selective agonist, in narcolepsy type 1[J]. N Engl J Med, 2025, 392(19): 1905-1916. [23] KIM S, JO K, HONG K B, et al. GABA and l-theanine mixture decreases sleep latency and improves NREM sleep[J]. Pharm Biol, 2019, 57(1): 65-73. [24] JOHNSON K A, MARTIN N, NAPPI R E, et al. Efficacy and safety of fezolinetant in moderate to severe vasomotor symptoms associated with menopause: a phase 3 RCT[J]. J Clin Endocrinol Metab, 2023, 108(8): 1981-1997. [25] YU Q, GUO Q, JIN S, et al. Melatonin suppresses sympathetic vasomotor tone through enhancing GABA(A) receptor activity in the hypothalamus[J]. Front Physiol, 2023, 14: 1166246. [26] OKAMOTO H H, CECON E, NUREKI O, et al. Melatonin receptor structure and signaling[J]. J Pineal Res, 2024, 76(3): e12952. [27] SAVINO R, POLITO A N, MARSALA G, et al. Agomelatine: a potential multitarget compound for neurodevelopmental disorders[J]. Brain Sci, 2023, 13(5): 734. [28] KLOSEN P, LAPMANEE S, SCHUSTER C, et al. MT1 and MT2 melatonin receptors are expressed in nonoverlapping neuronal populations[J]. J Pineal Res, 2019, 67(1): e12575. [29] PÉREZ-MORALES M, LÓPEZ-COLOMÉ A M, MÉNDEZ-DÍAZ M, et al. Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation[J]. Neurosci Lett, 2014, 578: 117-121. [30] LOSGOTT T, KUDLACEK O, YANG J W, et al. The paracetamol metabolite N-acetyl-4-benzoquinoneimine (NAPQI) prevents modulation of KV7 channels via G-protein coupled receptors by interference with PIP2 and Ca2+ sensitivity[J]. Br J Pharmacol, 2025, 182(6): 1341-1357. [31] KUME M, AHMAD A, SHIERS S, et al. C781, a β-arrestin biased antagonist at protease-activated receptor-2 (PAR2), displays in vivo efficacy against protease-induced pain in mice[J]. J Pain, 2023, 24(4): 605-616. [32] NASH J, MEAH M N, WHITTINGTON B, et al. PAR4 antagonism in patients with coronary artery disease receiving antiplatelet therapies[J]. Arterioscler Thromb Vasc Biol, 2024, 44(4): 987-996. [33] YANG D F, HUANG W C, WU C W, et al. Acute sleep deprivation exacerbates systemic inflammation and psychiatry disorders through gut microbiota dysbiosis and disruption of circadian rhythms[J]. Microbiol Res, 2023, 268: 127292. [34] LIU H, YANG C, WANG X, et al. Propofol improves sleep deprivation-induced sleep structural and cognitive deficits via upregulating the BMAL1 expression and suppressing microglial M1 polarization[J]. CNS Neurosci Ther, 2024, 30(7): e14798. [35] MOHAMMADI I, ADIBPARSA M, YASHOOA R K, et al. Effect of continuous positive airway pressure therapy on blood levels of IL-6, IL-10, IL-18, IL-1β, IL-4, and IL-17 in obstructive sleep apnoea adults: a systematic review, meta-analysis and trial sequential analysis[J]. Int Orthod, 2024, 22(4): 100917. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|